文献速递前列腺癌

局部晚期前列腺癌的发病率与死亡率:比较根治性前列腺切除术与外照射放疗的人群分析

Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation.
PubMed 文献 · J Urol · 2017-05-26

回顾性分析SEER-Medicare数据库中2935例65岁及以上局部晚期前列腺癌男性,比较外照射放疗与根治性前列腺切除术的毒性、雄激素剥夺治疗使用及死亡率;根治术组泌尿与性毒性风险更高、胃肠毒性风险更低、5年后雄激素剥夺治疗几率更低,但外照射放疗组总死亡与前列腺癌特异死亡风险更高。

要点

  • 根治术组泌尿毒性风险高于放疗组(HR 1.93,95%CI 1.66-2.24),性毒性风险亦更高(HR 5.50,95%CI 3.59-8.42)。
  • 根治术组胃肠毒性风险低于放疗组(HR 0.75,95%CI 0.65-0.86)。
  • 外照射放疗组总死亡风险(HR 1.41,95%CI 1.09-1.82)与前列腺癌特异死亡风险(HR 2.35,95%CI 1.85-2.98)均高于根治术组。

核心结论

  • 在65岁及以上局部晚期前列腺癌男性中,外照射放疗与根治性前列腺切除术在毒性和生存方面存在显著差异。
  • 作者指出该发现须在依赖行政索赔数据的研究局限性内解读,但仍可能有助于为局部晚期前列腺癌老年男性制定个体化治疗。

研究设计与样本

  • 回顾性分析SEER-Medicare关联数据库中2935例65岁及以上、接受外照射放疗或根治性前列腺切除术的局部晚期前列腺癌男性。
  • 采用倾向性调整的Cox比例风险模型和回归模型,评估泌尿与胃肠毒性、雄激素剥夺治疗使用及总死亡与前列腺癌特异死亡。

主要发现

  • 根治性前列腺切除术组1429例(48.69%),中位随访11.47年(IQR 6.17-17.17)。
  • 外照射放疗组1506例(51.31%),中位随访7.04年(IQR 4.11-10.51,p<0.001)。
  • 根治术组泌尿毒性风险(HR 1.93,95%CI 1.66-2.24)和性毒性风险(HR 5.50,95%CI 3.59-8.42)显著高于放疗组。
  • 根治术组胃肠毒性风险低于放疗组(HR 0.75,95%CI 0.65-0.86)。
  • 根治术组初次治疗后5年雄激素剥夺治疗几率低于放疗组(OR 0.53,95%CI 0.41-0.69,p<0.001)。

临床怎么用

  • 作者认为,尽管研究依赖行政索赔数据存在局限性,上述发现仍可能有助于为局部晚期前列腺癌老年男性制定个体化治疗。

局限性

  • 作者指出该发现须在依赖行政索赔数据的研究局限性内解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The management of locally advanced prostate cancer remains controversial. We compared the effect of primary external beam radiation therapy vs radical prostatectomy for locally advanced prostate cancer. MATERIALS AND METHODS: We retrospectively analyzed the records of 2,935 elderly men 65 years old or older in the SEER (Surveillance, Epidemiology and End Results)-Medicare linked database who underwent external beam radiation therapy or radical prostatectomy for locally advanced prostate cancer. Propensity adjusted Cox proportional hazard and regression models were fit to examine urinary and gastrointestinal toxicities, the use of androgen deprivation therapy, and overall and prostate cancer specific mortality. RESULTS: A total of 1,429 men (48.69%) underwent radical prostatectomy and had a median followup of 11.47 years (IQR 6.17-17.17) years. A total of 1,506 men (51.31%) received external beam radiation therapy and had a median followup of 7.04 years (IQR 4.11-10.51, p <0.001). Patients treated with radical prostatectomy were at significantly higher risk for urinary and sexual toxicities (HR 1.93, 95% CI 1.66-2.24 and HR 5.50, 95% CI 3.59-8.42, respectively). However, they were at lower risk for gastrointestinal toxicities (HR 0.75, 95% CI 0.65-0.86) than those treated with external beam radiation therapy. Radical prostatectomy was associated with lower odds of androgen deprivation therapy 5 years after primary treatment (OR 0.53, 95% CI 0.41-0.69, p <0.001). External beam radiation therapy was associated with higher overall and prostate specific mortality (HR 1.41, 95% CI 1.09-1.82 and HR 2.35, 95% CI 1.85-2.98, respectively). CONCLUSIONS: We found significant toxicity and survival differences in elderly men who underwent primary external beam radiation therapy vs radical prostatectomy for locally advanced prostate cancer. While our findings must be interpreted within the limitations of studies that rely on administrative claims, they may yet help tailor individual therapies for elderly men who present with locally advanced prostate cancer.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Feldman AS, Meyer CP, Sanchez A, et al. Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation. J Urol. 2017. PMID: 28552709. doi:10.1016/j.juro.2017.05.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。